Biologic features of HIV-1 that correlate with virulence in the host.

Individuals infected with the human immunodeficiency virus type 1 (HIV-1) may be asymptomatic or have AIDS-related complex or the acquired immuno deficiency syndrome (AIDS). Little is known about the factors that influence progression of infection to AIDS. In this study of isolates of HIV-1 obtained at intervals during the infection of four individuals, the development of disease was found to be correlated with the emergence of HIV-1 variants that were more cytopathic in vitro as the disease progressed and that replicated more efficiently in a wide variety of different human cells. The biologic properties of HIV-1 in vitro thus appear to reflect its virulence in the host. Further studies of such sequentially isolated viruses may lead to the identification of viral genes that govern pathogenesis.

[1]  S. Wain-Hobson,et al.  Genetic variability of the AIDS virus: Nucleotide sequence analysis of two isolates from African patients , 1986, Cell.

[2]  C. Cheng‐Mayer,et al.  Human immunodeficiency virus can productively infect cultured human glial cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Redfield,et al.  Genomic diversity of human T-lymphotropic virus type III (HTLV-III). , 1985, Science.

[4]  J. Levy,et al.  Recovery of AIDS-associated retroviruses from patients with AIDS or AIDS-related conditions and from clinically healthy individuals. , 1985, The Journal of infectious diseases.

[5]  J. Levy,et al.  Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. , 1985, Virology.

[6]  M. Hirsch,et al.  Infection of monocyte/macrophages by human T lymphotropic virus type III. , 1986, The Journal of clinical investigation.

[7]  D. Markovitz,et al.  The role of mononuclear phagocytes in HTLV-III/LAV infection. , 1986, Science.

[8]  J. Levy,et al.  Differential ability of human immunodeficiency virus isolates to productively infect human cells. , 1987, Journal of immunology.

[9]  P. Rubinstein,et al.  Prevalence, clinical significance, and strain specificity of neutralizing antibody to the human immunodeficiency virus. , 1987, The Journal of infectious diseases.

[10]  M. Reitz,et al.  In vitro generation of an HTLV-III variant by neutralizing antibody. , 1986, Journal of immunology.

[11]  J. Levy,et al.  Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. , 1984, Science.

[12]  J. Levy,et al.  AIDS-associated retroviruses (ARV) can productively infect other cells besides human T helper cells. , 1985, Virology.

[13]  J. Mcdougal,et al.  In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). , 1986, Journal of immunology.

[14]  G. Miller,et al.  Differences among human immunodeficiency virus strains in their capacities to induce cytolysis or persistent infection of a lymphoblastoid cell line immortalized by Epstein-Barr virus , 1987, Journal of virology.

[15]  N. Yamamoto,et al.  Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. , 1985, Science.